Enter to Win: Stock by chart challenge S11
Hello Mooers,
Normally stock prices fluctuate after the earnings release. Optimistic or pessimistic? Those things together can lead to big movement and create opportunities to trade! It's time to take a break! Let's check this game out and have fun!
![]()
【Rule】
Look at the charts below and tell the name of corresponding stocks.(i.e. Tesla, Apple, AMC)
![]()
【Validity period】
Please leave your comments by Monday Jan. 31, 9:00 AM ET / 10:00 PM SGT.
![]()
【Rewards】
The first and the last mooer who give correct answers within the validity period will win 288 points each!
![]()
Miss the first place?
Feel free to leave your comment about any of the stocks below, and 3 mooers will win extra 288 points each! (Based on quality and originality)
Normally stock prices fluctuate after the earnings release. Optimistic or pessimistic? Those things together can lead to big movement and create opportunities to trade! It's time to take a break! Let's check this game out and have fun!
Look at the charts below and tell the name of corresponding stocks.(i.e. Tesla, Apple, AMC)
Please leave your comments by Monday Jan. 31, 9:00 AM ET / 10:00 PM SGT.
The first and the last mooer who give correct answers within the validity period will win 288 points each!
Feel free to leave your comment about any of the stocks below, and 3 mooers will win extra 288 points each! (Based on quality and originality)
Chart 1: Keywords -
The company is a holding firm with three primary product categories: consumer health, medical devices, and pharmaceutical products, and it also participates in the fight against covid-19. The vaccines developed by the company's division protect against severe Coronavirus infections. The total market capitalization now stands at $449.095 billion.
The company is a holding firm with three primary product categories: consumer health, medical devices, and pharmaceutical products, and it also participates in the fight against covid-19. The vaccines developed by the company's division protect against severe Coronavirus infections. The total market capitalization now stands at $449.095 billion.
Chart 2: Keywords -
This company is the world's largest manufacturer of semiconductor chips and the first company to produce x86 port processors. It also produces many computing-related devices, such as motherboard chipsets embedded processors.
This company is the world's largest manufacturer of semiconductor chips and the first company to produce x86 port processors. It also produces many computing-related devices, such as motherboard chipsets embedded processors.
Chart 3: Keywords -
The company is a major supplier of microprocessors, specializing in manufacturing semiconductor devices used in computer processing. The company also produces various components for electronic products. Total market capitalization reached $123.901 billion.
The company is a major supplier of microprocessors, specializing in manufacturing semiconductor devices used in computer processing. The company also produces various components for electronic products. Total market capitalization reached $123.901 billion.
Have a wonderful weekend!
Disclaimer: Stock by Chart Challenge is for entertainment purposes only. It does not provide any investments or financial advice.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Moomoo Community Official Account
Host moomoo contests and giveaways!
77KFollowers
394Following
28KVisitors
Follow
PlutoMoo102685100 : $Johnson & Johnson (JNJ.US)$$Intel (INTC.US)$
$Advanced Micro Devices (AMD.US)$
PlutoMoo102685100 PlutoMoo102685100 :
PlutoMoo102685100 PlutoMoo102685100 :
An Early Happy Chinese New Year Everyone
https://www.moomoo.com/community/feed/107689670868998?lang_code=2&data_ticket=2ae960d3da29d3eb69b08b5f04d83c75
Qui Vivra Verra : $Johnson & Johnson (JNJ.US)$
$Intel (INTC.US)$ $Advanced Micro Devices (AMD.US)$
Syuee : One of the reasons investors should trust $Johnson & Johnson (JNJ.US)$ if a crash materializes is the defensive nature of healthcare stocks. No matter how well or poorly the U.S. economy and stock market are performing, people will continue to get sick and require prescription drugs, medical devices, and healthcare services/products.
This certainty of demand allows the company to accurately forecast its sales, cash flow, and profit growth well in advance.
$Johnson & Johnson (JNJ.US)$ aims to expand its pharmaceutical sales by 5% annually, to $60 billion, by 2025 and have 13 drugs with annual sales of $1 billion or more.
For 2022, the pharmaceutical giant expects to earn $10.40-$10.60 per share on $98.9 billion to $100.4 billion in sales. The sales estimate includes a potential $3 billion to $3.5 billion from its Covid vaccine.
HuatEver Syuee : You are right in your prediction that $Johnson & Johnson (JNJ.US)$ stock will not affected by US recession Nor the market’s decline because people are dependent on medication and the use of health care products or devices when they fall sick.
HuatLady Syuee : Who can challenge the sales of this giant pharmaceutical company, especially during this Coronavirus epidemic, when vaccines are in great demand?
PlutoMoo102685100 : @Syuee@HopeAlways@HuatEver@HuatLady
J&J planning to split
https://www.cnbc.com/amp/2022/01/10/johnson-johnson-spin-off-consumer-division.html
Questions are @HuatEverand @HuatLadyhusband and wife duo?
Also are you related to @HopeAlways?
71068720 : $Johnson & Johnson (JNJ.US)$$Intel (INTC.US)$
$Advanced Micro Devices (AMD.US)$
HopeAlways : The start of a new year is an ideal time to search for underperforming stocks that could be on the verge of a rebound. One relatively cheap stock that stands out is $Intel (INTC.US)$. While $Intel (INTC.US)$ has lost considerable market share to competitors in recent years, it still commands the lion's share of chip sales and CEO Pat Gelsinger has a clear roadmap to regain share, including a new foundry service. Its consistent free cash flow funds an increasing dividend to shareholders. The market does not appear to give $Intel (INTC.US)$ any credit for its growth plans. As it speeds up innovation and gets back on track, there is a reasonable chance that $Intel (INTC.US)$ may outperform the broader market from its lower levels.
View more comments...